Stock screener

KPTI

Conviction 35HealthcareScan · Mon, Aug 10, 2026
KPTI$1.95-8.02%
ResistanceSupportVol 14Insider sell
63 bars
6
Vol MA14 3.5M
May 11May 28Jun 16Jul 6Jul 23Aug 10
Karyopharm Therapeutics Inc.PHARMACEUTICAL PREPARATIONSwww.karyopharm.com
Price1.95
Change-8.02%
Gap+1.18%
Rel volume1.86×
Avg volume2.67M
Avg $ vol8.74M
SMA 205.86
SMA 508.04
SMA 2007.51
Price vs 50-75.74%
Price vs 200-74.02%
MA stackmixed
50/200 cross
Supertrenddown · 4.21
RSI (14)18
MACD hist-0.46
MACD cross
Stoch %K / %D2 / 3
ADX (14)45
+DI / −DI12 / 47
RSI divergence
MACD divergence
ATR %+38.47%
ADR %11.13%
52w high10.67
52w low1.91
From 52w high-81.72%
Above 52w low+2.09%
New 52w highNo
SqueezeOff
Bollinger width204.68%
%B0.17
Donchian pos1.79%
Donchian high10.17
Donchian low1.80
AVWAP (52w high)5.85
vs AVWAP high-66.64%
AVWAP (52w low)2.02
vs AVWAP low-3.48%
OBV trendDown
Chaikin MF (20)-0.30
Today vs 20d1.86×
Avg vol (14d)3.5M
Avg vol (20d)2.67M
Avg $ vol (20d)8.74M
Market cap44.19M
RS 3m (vs SPY)-81.74%
RS 6m (vs SPY)-79.30%
RS line new highNo
Trend template2/8
Technical rank5.0
1 week-1.02%
1 month-81.14%
3 months-77.43%
6 months-68.85%
1 year-50.88%
YTD-72.88%
P/E-0.23
P/B-0.17
P/S0.30
P/FCF-0.59
EPS-17.93
Div yield
ROE73.80%
ROA-149.17%
Debt/Eq-0.64
Current1.08
EV/EBITDA-1.37
Gross margin
Net margin-134.21%
Rev growth0.57%
EPS growth-156.52%
Price target7.20
Target upside269.23%
Analyst ratingBuy
Institutional87.65%
Ent. value122.64M
Revenue35.07M
Net income-22.39M
Gross profit
Free cash flow-75.37M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out
Employees228
ListedWed, Nov 6, 2013
Free float17.98M
Float %98.0%
Short interest6.31M
Days to cover17.1d
Short volume43.0%
Squeeze score80 / 100
Next earnings
EPS forecast
Last EPS vs est−$1.24 vs −$1.45
Last surprise+14.5% beat
Setup gradeD
Conviction35 / 100
Pattern quality
Tech rank5.0 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction
Pattern family
Resistance10.67
Support1.80
Days since event
Candle confirm
News sentiment

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KPTI

All disclosures →
No recent disclosed trades by Congress in KPTI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KPTI · 6 buys · 4 sells

InsiderSideShares
PAKIANATHAN DEEPIKA
Director · Common Stock · 2026-05-21
Grant15.51K
Su Zhen
Director · Common Stock · 2026-05-21
Grant15.51K
Schor Chen
Director · Common Stock · 2026-05-21
Grant15.51K
Greene Barry E
Director · Common Stock · 2026-05-21
Grant15.51K
Oliger Christy J.
Director · Common Stock · 2026-05-21
Grant15.51K
BOHLIN GAREN G
Director · Common Stock · 2026-05-21
Grant15.51K
Poulton Stuart
EVP, Chief Development Officer · Common Stock · 2026-05-14
Sell403
Cheng Sohanya Roshan
EVP & Chief Commercial Officer · Common Stock · 2026-05-14
Sell324
Paulson Richard A.
President and CEO · Common Stock · 2026-05-14
Sell2.2K
Abate Kristin
Chief Accounting Officer · Common Stock · 2026-05-14
Sell53

SEC filings

EDGAR filings in KPTI · 4 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.